Sporadic Pancreatic Polypeptide Secreting Tumors (PPomas) of the Pancreas
- 188 Downloads
Sporadic pancreatic neuroendocrine tumors, which predominantly secrete pancreatic polypeptide (PPoma), are rare and have not been associated with a clinical syndrome. A wider understanding of their pathological features and behavior is needed.
Four PPoma patients who presented with nonspecific abdominal pain are described. Their diagnosis was established by the presence of an enhancing solitary pancreatic tumor on computed tomography (CT) and elevated fasting pancreatic polypeptide hormone levels. Patient 1 was treated with a pancreatoduodenectomy because of elevation of serum CEA level. Two of the cases underwent enucleation because of prolonged stable CT appearance. Patient 4 underwent distal pancreatectomy for a pancreatic neck tumor causing ductal obstruction and distal parenchymal atrophy.
All cases had benign histological features apart from patient 1 whose tumor demonstrated occasional mitotic activity. These tumors have not recurred after a median of 49 (range, 35–57) months. The protein expression in the tumor tissue was measured by SELDI-TOF MS and was different than the profile of pancreatic adenocarcinoma that was previously demonstrated in our laboratory. This may lead to future helpful diagnostic testing on fine needle aspirates.
Resection of sporadic PPomas presenting as a solitary well-defined mass with benign histological features results in good long-term survival.
KeywordsPancreatic Adenocarcinoma Pancreatic Polypeptide Islet Cell Tumor Pancreatic Neuroendocrine Tumor Royal North Shore Hospital
- 1.DeLellis RA, Lloyd R, Hietz PU, Eng C (2004) World Health Organisation classification of tumours, pathology and genetics: tumour of endocrine organsGoogle Scholar
- 4.Chance RE, Jones WE (1974) Polypeptides from bovine, ovine, human and porcine pancreas. 842, 63. US Patent. Ref type: patentGoogle Scholar
- 6.Vinik AI, Achem-Karam S, Owyang C (1982) Gastrointestinal hormones in clinical medicine. In: Cohen MP, Fogar P (eds) Special topics in endocrinology and metabolism. Alan R. Liss, New York, pp 93–138Google Scholar
- 7.Vinik A, Glaser B (1981) Pancreatic endocrine tumors. In: Dent TL (ed) Pancreatic disease. Grune & Stratton, New York, 427 ppGoogle Scholar
- 15.Nobin A, Berg M, Ericsson M, Ingemansson S, Olsson E, Sundler F (1984) Pancreatic polypeptide-producing tumors. Report on two cases. Cancer 53:2688–2691Google Scholar
- 20.Tomita T, Friesen SR, Kimmel JR (1986) Pancreatic polypeptide-secreting islet cell tumor. A follow-up report. Cancer 57:129–133Google Scholar
- 21.Guiro F, Mortara G, Schiaffino E, d’Urbano C (1994) Pancreatic Endocrine F-cell Tumor. Rev Esp Enferm Dig 86:694–698Google Scholar
- 22.Levy-Bohbot N, Merle C, Goudet P, Delemer B, Calender A, Jolly D, Thiefin G, Cadiot G (2004) Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. Gastroenterol Clin Biol 28:1075–1081PubMedCrossRefGoogle Scholar
- 30.Larsson LI, Schwartz T, Lundqvist G, Chance RE, Sundler F, Rehfeld JF, Grimelius L, Fahrenkrug J, Schaffalitzky DM, Moon N (1976) Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome. Am J Pathol 85:675–684PubMedGoogle Scholar
- 33.Norton JA (2001) Endocrine tumours of the pancreas. In: Lennard TWJ (ed) Endocrine surgery. ElsevierGoogle Scholar